Webflow Homepage
Veterinarians
Services For
Canine lymphoma & Leukemia
Personalized Prediction Profile
AI-Driven Drug Response Predictions
(Flow Cytometry + PARR included)
Drug Response Predictions
NEW
Personalize anticancer drug treatment decisions with confidence
Immunoprofile
Get accurate diagnostic support from the start (Flow Cytometry + PARR)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Multidrug Sensitivity Genotyping (MDR1)
Identify MDR1 carrier status with ease
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
Services For
FELINE lymphoma & Leukemia
Immunoprofile
Get accurate diagnostic support from the start (PARR + Flow Cytometry)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
for
veterinarians
Order Services via Vet Portal
Request Pricing
Clinical Case Studies
Our Science & Publications
Participate in Our Research
💖 Wall of Love: Customer Reviews
Veterinary Cancer Pioneers Podcast
Contact Us
Pet Parents
LEARN
How It Works
Dog Lymphoma 101
Cat Lymphoma 101
Our Science & Publications
Blog
Content Library
Get Started
Find a Veterinary Oncologist
Talk to Your Veterinarian
Customer stories & Case Studies
ImpriMed Reviews
Discover what other pet parents are saying and how oncologists use ImpriMed's reports
Human Oncology
CRO
Company
Company
Our Science & Publications
About Us
Careers
Events
Press
Contact Us
Contact Us
Other Links
ImpriMed Korea
Pricing
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Find a Vet
Get Started
Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Press Releases
ImpriMed AI and machine learning is disrupting the veterinary oncology tools available for better treatment outcomes
EIN Presswire
Learn More →
Presentations
Precision medicine for pet cancer care
Animal Health, Nutrition and Technology Innovation Europe 2022
Learn More →
Press Releases
ImpriMed Publishes Exclusive Canine Patients Data Analysis
EIN Presswire
Learn More →
In the News
AI’s Computing Power Could Make Fusion Energy Practical
Lifewire
Learn More →
Press Releases
ImpriMed CEO and Co-founder Dr. Sungwon Lim Wins Prestigious “Top Industry Leader” Award from Life Sciences Voice
EIN Presswire
Learn More →
Press Releases
ImpriMed Reports Significant Growth in 2021 with Pre-Series A Funding, New Product Launches, and Team Expansion
EIN Presswire
Learn More →
Video/Podcast Interviews
Personalized Medicine in Veterinary Oncology
Veterinary Innovation Podcast
Learn More →
In the News
Don't Guess Your Pet's Condition, Treat It with ImpriMed
Startup to Follow
Learn More →
Scientific Publications
Predicting Dynamic Clinical Outcomes of the Chemotherapy for Canine Lymphoma Patients Using a Machine Learning Model
Veterinary Sciences
Learn More →
Presentations
ImpriMed: Experiences from the eyes of an oncologist in clinical practice
Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model
Veterinary Cancer Society Annual Conference 2021
Learn More →
Press Releases
ImpriMed Launches New Diagnostic Services for Canine Lymphoma
EIN Presswire
Learn More →
In the News
Interview with ImpriMed CEO & Co-Founder Sungwon Lim
IdeaMensch
Learn More →
Video/Podcast Interviews
Interview with Dr. Sungwon Lim, CEO of ImpriMed
Innovating with Scott Amyx
Learn More →
Video/Podcast Interviews
Tech Founder Interview with Sungwon Lim, CEO & Founder of ImpriMed
Tech Founder Show by Insivia
Learn More →
Press Releases
ImpriMed Initiates Feline Lymphoma Drug Response Prediction Study
EIN Presswire
Learn More →
In the News
This Test Might Make All The Difference When Fighting Lymphoma
Canine Cancer Alliance
Learn More →
Press Releases
ImpriMed Launches Chemo Response Prediction and Immunophenotyping Services for Canine Lymphoma
GlobeNewswire
Learn More →
Previous
Next
